SCHEMBL11922560

SCHEMBL11922560

COC(=O)c1cc(Oc2ccc(C=O)cc2C(F)(F)F)c(F)cc1NC(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESRRA P11474 4/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ ALDH1A1 P00352 6/20 0.36
▸ HPGD P15428 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.34
▸ POLB P06746 2/20 0.33
▸ PKM P14618 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ AKR1C2 P52895 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ APP P05067 1/20 0.32
▸ CFTR P13569 1/20 0.32
▸ KIF11 P52732 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11922566 0.85 ESRRA (0.42) ESRRACYP3A4ALDH1A1HPGDCYP1A2
SCHEMBL11922610 0.84 SCN9A (0.34) ALDH1A1MAPTKDM4EPOLBCFTR
SCHEMBL11922609 0.77 P2RY1 (0.46) MAPTCFTR
SCHEMBL13044881 0.75 ESRRA (0.33) ESRRACYP3A4ALDH1A1HPGDCYP1A2
SCHEMBL13947535 0.75 ESRRA (0.33) ESRRACYP3A4ALDH1A1HPGDCYP1A2
SCHEMBL11922556 0.73 MRGPRX4 (0.35) ESRRACYP3A4ALDH1A1MAPTKDM4E
SCHEMBL498274 0.72 ALDH1A1 (0.49) ESRRAALDH1A1HPGDCYP1A2HSP90AA1
SCHEMBL11991627 0.71 CYP3A4 (0.32) ESRRACYP3A4ALDH1A1HPGDCYP1A2
SCHEMBL11922620 0.71 KMT2A (0.36) ESRRAALDH1A1MAPTSMN1; SMN2KDM4E
SCHEMBL13044873 0.70 KDM4E (0.42) ALDH1A1HPGDMAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242140-B2 Viral polymerase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-08-14 — — US disclosed
US-8242140-B2 Viral polymerase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-08-14 — — US disclosed
US-20100190779-A1 VIRAL POLYMERASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-07-29 — — US disclosed
US-20100190779-A1 VIRAL POLYMERASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-07-29 — — US disclosed
WO-2009018657-A1 VIRAL POLYMERASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190779-A1 VIRAL POLYMERASE INHIBITORS POLR2A, POLR2H, POLR2E ESRRA 1853/4885CYP3A4 745/4885ALDH1A1 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback